Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting

First clinical data for dapolsertib monotherapy: initial results from the Phase II JASPIS-01 study…

SEMA 2026: CARKU Showcases LiFePO4 and Sodium-Ion Jump Starters as It Strengthens North American Aftermarket Partnerships

LAS VEGAS, Nov. 5, 2026 /PRNewswire/ — As a returning exhibitor at SEMA…

Redis Expands Redis Iris to Give AI Agents the Memory, Context, and Messaging They Need to get to Production

SAN FRANCISCO, Nov. 5, 2026 /PRNewswire/ — Redis today announced the next…

G Adventures reveals eight destinations to watch for 2027

Annual forecast spotlights trending destinations driven by expanded air routes and new…

7 in 10 workers surveyed in Singapore have considered leaving due to increased workloads, new research finds

New Top Employers Institute research finds 71% have considered leaving due to…

Gastops and Anschütz to Collaborate on Canadian Patrol Submarine Project Sustainment

PARIS  , Nov. 5, 2026 /PRNewswire/ — Gastops, a leader in intelligent…

Agthia Reports Revenue Growth Amid Challenging Cost Environment

ABU DHABI, UAE, Nov. 5, 2026 /PRNewswire/ — Agthia Group PJSC (AGTHIA:UH),…

Agthia Reports Revenue Growth Amid Challenging Cost Environment

ABU DHABI, UAE, Nov. 5, 2026 /PRNewswire/ — Agthia Group PJSC (AGTHIA:UH),…